Allon Therapeutics Inc.
NPCUF
$0.0001
$0.000.00%
OTC PK
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Net Income | 85.05% | -282.54% | 42.14% | -15.72% | 27.21% |
| Total Depreciation and Amortization | -98.65% | -13.98% | 0.39% | -1.31% | 1.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.21% | 4,126.29% | -55.85% | 65.95% | 78.05% |
| Change in Net Operating Assets | -73.90% | 184.78% | -250.17% | 542.37% | 152.34% |
| Cash from Operations | 61.24% | 28.49% | -33.08% | 12.44% | 37.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 1,804.83% | -88.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 101.01% | -15,643.24% | -100.67% |
| Cash from Financing | -- | 2,142.37% | -99.91% | 114.64% | -36.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.48% | 33.09% | -165.40% | 652.57% | -28.26% |